Use of activated protein C has no avail in the early phase of acute pancreatitis

HPB

Volumn 10, Issue 6, 2008, Pages 459-463

  Akay, Sinan ^a   Ozutemiz, Omer ^a   Yenisey, Cigdem ^b   Genc Simsek, Nilufer ^b   Yuce, Gul ^a   Batur, Yucel ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b ADNAN MENDERES UNIVERSITY   (Turkey)

Author keywords

Activated protein C; Acute pancreatitis; Catalase; Drotrecogin alfa; Glutathione peroxidase; Glutathione reductase; Myeloperoxidase; Oxidative stress

Indexed keywords

AMYLASE; CATALASE; CREATININE; DROTRECOGIN; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; INTERLEUKIN 6; MYELOPEROXIDASE; SODIUM CHLORIDE; TAUROCHOLIC ACID; UREA;

ACUTE HEMORRHAGIC PANCREATITIS; AMYLASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BOLUS INJECTION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFICACY; ENZYME ACTIVITY; HISTOPATHOLOGY; MALE; NONHUMAN; PANCREAS; RAT; SCORING SYSTEM; UREA BLOOD LEVEL;

EID: 57049091245     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1080/13651820802140729     Document Type: Article

References (24)

1. Norman, JG. (1999) New approaches to acute pancreatitis: Role of inflammatory mediators. Digestion, 60, pp. 57-60.
2. Pereda, J., Sabater, L., Aparisi, L., Escobar, J., Sandoval, J. Vina, J. et al. (2006) Interaction between cytokines and oxidative stres in acute pancreatitis. Curr Med Chem, 13, pp. 2775-2787.
3. Bernard, GR, Ely, EW, Right, TJ, Fraiz, J., Stasek Jr, JE Russel, JA et al. (2001) Safety and dose relationship of recombinant human activated protein C for coagulopathy in severe sepsis. Crit Care Med, 29, pp. 2051-2059.
4. Ottesen, LH, Bladbjerg, EM, Osman, M., Lausten, SB, Jacobsen, NO Gram, J. et al. (1999) Protein C activation during the initial phase experimental acute pancreatitis in the rabbit. Dig Surg, 16, pp. 486-495.
5. Radenkovic, D., Bajec, D., Karamarkovic, A., Stefanovic, B., Milic, N. Ignjatovic, S. et al. (2004) Disorders of hemostasis during surgical management of severe necrotizing pancreatitis. Pancreas, 29, pp. 152-156.
6. Fourrier, F. (2004) Recombinant human activated protein C in the treatment of severe sepsis: An evidence based review. Crit Care Med, 32, p. S534.
7. Wilson, PG, Manji, M. and Neoptolemos, JP. (1998) Acute pancreatitis as a model of sepsis. J Antimicrob Chemother, 41, pp. 51-63.
8. Schwarz, M., Thomsen, J., Meyer, H., Buchler, MW and Beger, HG. (2000) Frequency and time course of pancreatic and extrapancreatic bacterial infection in experimental acute pancreatitis in rats. Surgery, 127, pp. 427-432.
9. Spormann, H., Sokolowski, A. and Letko, G. (1989) Effect temporary ischemia upon development and histological patterns of acute pancreatitis in the rat. Pathol Res Pract, 184, pp. 507-513.
10. Dogan, AL, Dogan, A., Canpinar, H., Duzguncinar, O. and Demirpence, E. (2004) Effect of fludarabine on leukocyte functions. Chemotheraphy, 50, pp. 283-288.
11. Beutler, E. (1969) Effect of flavin compounds on glutathione reductase activity: In vivo and in vitro studies. J Clin Invest, 48, pp. 1957-1966.
12. Paglia, DE and Valentine, WN. (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med, 70, pp. 158-169.
13. Aebi, H., Wyss, SR, Scherz, B. and Skvaril, F. (1974) Heterogeneity of erythrocyte catalase II. Isolation and characterization of normal and variant erythrocyte catalase and their subunits. Eur J Biochem, 48, pp. 137-145.
14. Lowry, OH, Rosebrough, NJ, Farr, AL and Randall, RJ. (1951) Protein measurement with the Folin phenol reagent. J Biol Chem, 193, pp. 265-275.
15. Urunuela, A., Sevillano, S., de la Mano, AM, Manso, MA, Orfao, A. and de Dios, I. (2002) Time course of oxygen-free radical production in acinar cells during acute pancreatitis induced by pancreatic duct obstruction. Biochim Biophys Acta, 1588, pp. 159-164.
16. Dabrowski, A., Konturek, SJ, Konturek, JW and Gabryelewicz, A. (1999) Role of oxidative stress in the pathogenesis of caerulein-induced acute pancreatitis. Eur J Pharmacol, 377, pp. 1-11.
17. Kruse, P., Anderson, ME and Loft, S. (2001) Minor role of oxidative stress during intermediate phase of acute pancreatitis in rats. Free Radic Biol Med, 30, pp. 309-317.
18. Matthay, M. (2001) Severe sepsis - a new treatment with both anticoagulant and antiinflammatory properties. N Engl J Med, 344, pp. 759-762.
19. Heath, DI, Cruickshank, A., Gudgeon, M., Jehanli, A., Shenkin, A. and Imrie, JW. (1993) Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Gut, 34, pp. 41-45.
20. Li, Y., Du, B., Pan, JQ, Chen, DC and Liu, DW. (2006) Up-regulation interleukin-6 and interleukin-8 by activated protein C in lipopolysaccharide-treated human umbilical vein endothelial cells. J Zhejiang Univ Sci B, 7, pp. 899-905.
21. Yamanel, L., Mas, MR, Comert, B., Isik, AT, Aydin, S. Mas, N. et al. (2005) The effect of activated protein C on experimental acute necrotizing pancreatitis. Crit Care, 9, pp. 184-190.
22. Chen, P., Zhang, Y., Qiao, M. and Yuan, Y. (2007) Activated protein C, an anticoagulant polypeptide, ameliorates severe acute pancreatitis via regulation of mitogen activated protein kinases. J Gastroenterol, 42, pp. 887-898.
23. Heeb, MJ, Gruber, A. and Griffin, JH. (1991) Identification of divalent metal ion-dependent inhibition of activated protein C by alpha 2-macroglobulin and alpha 2-antiplasmin in blood and comparisons to inhibition of factor Xa, thrombin, and plasmin. J Biol Chem, 266, pp. 17606-17612.
24. Wiedermann, CJ and Kaneider, NJ. (2005) A meta-analysis of controlled trials of recombinant human activated protein C therapy in patients with sepsis. BMC Emerg Med, 14, pp. 5-7.